LOS ANGELES--March 31, 2005
Universal Detection Technology (OTCBB:UDTT) today announced that its Anthrax Smoke Detector (ASD) Technology was evaluated by an official from the Defense Threat Reduction Agency (DTRA) as part of a DTRA effort to assess technologies with Standoff Bio-detection capabilities. DTRA is a combat support agency of the U.S. Department of Defense and is responsible for reducing the present threat to the U.S. and its allies from weapons of mass destruction and preventing future threats.
"In recent years a lot of resources have gone into developing technologies for point detection while the DTRA is also interested in technologies with Standoff Detection capabilities. In other words, they are interested in devices that are autonomous and can work continually to distinguish a plume of dust form a plume of deadly biological pathogens," says UDT's Director of R&D, Amir Ettehadieh. "UDT's Bacterial Spore Monitor is capable of continuously monitoring the ambient air for a rise in the level of bacterial spores, which is a likely indicator of an airborne anthrax attack," adds Amir Ettehadieh.
About Universal Detection Technology
Universal Detection Technology (UDTT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Management believes that the Company's technology, together with third party technologies and devices, has positioned it to capitalize on growth and value opportunities related to Homeland Security. UDTT, in cooperation with NASA's Jet Propulsion Laboratory (JPL), has developed a bio-terror `smoke' detector, which combines JPL's spore detection technology with UDTT's aerosol capture device.
For more information, please visit http://udtt.invrel.net or http://www.udetection.com.
About Defense Threat Reduction Agency
The Defense Threat Reduction Agency (DTRA) was established in 1998. DTRA is responsible for reducing the present threat to the U.S. and its allies from weapons of mass destruction and preventing future threats. The agency supports the United States' nuclear deterrent capability; reduces the threat from nuclear, chemical, biological, and other special and conventional weapons, and counters threats posed by WMD. DTRA has a world-wide presence with offices at Fort Belvoir and Alexandria, VA; Albuquerque, NM; and San Francisco, CA. Overseas locations include Frankfurt, Germany; Almaty, Kazakhstan; Moscow and Votkinsk, Russia; Kiev, Ukraine; and Yokota, Japan.
Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt, our ability to timely and cost effectively complete the development and testing of our products targeted to the bio-chemical market, our ability to commercially produce our products on a profitable basis, commercial acceptance of our products, product price volatility, product demand, market competition and general economic conditions, and other factors described in the Company's filings with the Securities and Exchange Commission. We undertake no obligation and do not intend to revise or update publicly any forward looking statements for any reason.